Naftidrofuryl--a double blind cross-over study in the elderly.
D000203:Activities of Daily Living; D000284:Administration, Oral; D000368:Aged; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D004048:Diethylamines / Q000009:adverse effects / Q000627:therapeutic use; D005663:Furans / Q000009:adverse effects / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D007361:Intelligence Tests; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008568:Memory / Q000187:drug effects; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D011594:Psychometrics; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D004048:Diethylamines; D005663:Furans; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates; D014665:Vasodilator Agents